Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

How Are You Handling Big Data & Innovation?

Posted on April 28th, 2017 by in Pharma R&D

Although every pharmaceutical company still hopes to find the next blockbuster drug, today’s R&D departments are becoming increasingly focused on developing more targeted therapies. It is the advent of Big Data that has made it possible for researchers to advance precision medicine and targeted drugs Continue reading “How Are You Handling Big Data & Innovation?” »

Assessing Our Progress and Looking Ahead

Posted on April 21st, 2017 by in The Hive

Like many start-ups, Reset Therapeutics has been driven by big ideas, which we have pursued with passion, commitment and accountability. Continue reading “Assessing Our Progress and Looking Ahead” »

Reaxys: Increasing Efficiency in the Lab

Posted on April 19th, 2017 by in Chemistry

Bruce Clapham is Director and Head of Medicinal Chemistry at the San Francisco-based Reset Therapeutics, a start-up dedicated to using the body’s natural circadian system to discover and develop new therapies. “My job is to run the chemistry lab and to be a leader in the design of new molecules Continue reading “Reaxys: Increasing Efficiency in the Lab” »

Organ-on-Chip: Efficient Translational Platform

Posted on December 12th, 2016 by in Pharma R&D

Several years ago, cellular and subcellular platforms aimed to replace in vivo animal testing. Cellular and molecular scientists, armed with their pipettes, shouted the battle hymn of the translational scientist: “From bench to bedside.” Continue reading “Organ-on-Chip: Efficient Translational Platform” »

  1. 1
  2. 2
  3. 3
  4. 7